MAPK3 and familial dilated cardiomyopathy: To further study the mechanism of SPD alleviating DCM, we used P2X7 specific inhibitor (A-438079) and ERK1/2 signaling pathway blocker (LY3214996) to treat with cardiomyocytes separately.